SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041605
Filing Date
2023-08-11
Accepted
2023-08-11 07:31:03
Documents
70
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pyxs-20230630.htm   iXBRL 10-Q 2851199
2 EX-10.1 pyxs-ex10_1.htm EX-10.1 45357
3 EX-31.1 pyxs-ex31_1.htm EX-31.1 20221
4 EX-31.2 pyxs-ex31_2.htm EX-31.2 20228
5 EX-32.1 pyxs-ex32_1.htm EX-32.1 12404
6 EX-32.2 pyxs-ex32_2.htm EX-32.2 11711
7 GRAPHIC img31498571_0.jpg GRAPHIC 81835
  Complete submission text file 0000950170-23-041605.txt   8962059

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pyxs-20230630_pre.xml EX-101.PRE 290480
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pyxs-20230630.xsd EX-101.SCH 45355
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pyxs-20230630_cal.xml EX-101.CAL 34093
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pyxs-20230630_def.xml EX-101.DEF 168054
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pyxs-20230630_lab.xml EX-101.LAB 389722
64 EXTRACTED XBRL INSTANCE DOCUMENT pyxs-20230630_htm.xml XML 1466651
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40881 | Film No.: 231161530
SIC: 2834 Pharmaceutical Preparations